circEPSTI1 acts as a ceRNA to regulate the progression of osteosarcoma.

CONCLUSION: Thus, the circEPSTI1-miR-892b-MCL1 axis affected osteosarcoma progression through miRNA sponging mechanism. circEPSTI1 may serve as a target and biomarker for osteosarcoma treatment. PMID: 31702512 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31702512?dopt=Abstract

Source: Current Cancer Drug Targets - November 6, 2019 Category: Cancer & Oncology Authors: Tan X, Tan D, Li H, Lin Y, Wen Z, Zeng C Tags: Curr Cancer Drug Targets Source Type: research